The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders ...

Synchron successfully implanted the first FDA-approved brain-computer interface in a U.S. patient with ALS. The device ...

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

A New York-based biotech firm announced it has raised an additional $200 million in financing to advance commercialization of ...

Remember how, last week, we talked about tech giant Microsoft ($MSFT) and its plans to get AI involved in medicine? Well, ...

Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish ...

Researchers in Shanghai have reported in a study, recently published in Science Advances, that they've successfully decoded ...

INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced a strategic collaboration with Microsoft to explore ...

SCI Ventures’ investment in Precision reflects the firm's belief in the potential impact of the BCI field. The fund provides not only capital but also deep networks of clinicians, regulatory experts, ...

Australia has invested $54 million in Melbourne-born brain-computer interface company Synchron, the federal government’s ...

Reading brain activity with advanced technologies is not a new concept. However, most techniques have focused on identifying ...

Last month, a study showed Science Corp.’s PRIMA BCI retinal implant restored some vision to people with severe age-related macular degeneration. Meanwhile, Elon Musk’s Neuralink earlier this year ...